PFKP and non-small cell lung carcinoma: In order to better pave the road for future clinical translation, further pre-clinical studies in this field should examine the effects of various HBO dosing regimens on lung tumor growth, HIF-1α and PFKP expression, EMT marker expression, metastatic spread, and survival rates in both orthotopic and autochthonous models of NSCLC.